Stage III non-small cell lung cancer (NSCLC) includes a highly heterogeneous group of patients with differences in the extent and localization of disease. Many aspects of stage III disease are controversial. The data supporting treatment approaches are often subject to a number of limitations, due t...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!